Given the constitutively active nature of EWSR1-ATF1, it is tempting to speculate that the expression of the fusion protein in CCS, combined with the genomic retargeting of TFAP2A, SOX10, and MITF, may sustain an invasive phenotype that mimics MM progression. The gene discussed is EWSR1; the disease is Miyoshi myopathy.